The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 12, 2006
Filed:
Apr. 06, 2004
Joerg Brandenburg, Wiesbaden, DE;
Kai Donsbach, Glen Allen, VA (US);
Hans-dieter Ecker, Gau-Algesheim, DE;
Rogelio Perez Frutos, Sandy Hook, CT (US);
Fabrice Gallou, Danbury, CT (US);
Dieter Gutheil, Bad Kreuznach, DE;
Nizar Haddad, Danbury, CT (US);
Robert Hagenkoetter, Idstein, DE;
Dirk Kemmer, Guldental, DE;
Jutta Kroeber, Bingen-Dietersheim, DE;
Thomas Nicola, Ingelheim, DE;
Juergen Schnaubelt, Biberach, DE;
Michael Schul, Plaidt, DE;
Robert Donald Simpson, Wilmington, DE (US);
Xudong Wei, Ridgefield, CT (US);
Eric Winter, Gau-Algesheim, DE;
Yibo Xu, New Milford, CT (US);
Nathan K. Yee, Danbury, CT (US);
Joerg Brandenburg, Wiesbaden, DE;
Kai Donsbach, Glen Allen, VA (US);
Hans-Dieter Ecker, Gau-Algesheim, DE;
Rogelio Perez Frutos, Sandy Hook, CT (US);
Fabrice Gallou, Danbury, CT (US);
Dieter Gutheil, Bad Kreuznach, DE;
Nizar Haddad, Danbury, CT (US);
Robert Hagenkoetter, Idstein, DE;
Dirk Kemmer, Guldental, DE;
Jutta Kroeber, Bingen-Dietersheim, DE;
Thomas Nicola, Ingelheim, DE;
Juergen Schnaubelt, Biberach, DE;
Michael Schul, Plaidt, DE;
Robert Donald Simpson, Wilmington, DE (US);
Xudong Wei, Ridgefield, CT (US);
Eric Winter, Gau-Algesheim, DE;
Yibo Xu, New Milford, CT (US);
Nathan K. Yee, Danbury, CT (US);
Boehringer Ingelheim International GmbH, Ingelheim, DE;
Abstract
Disclosed is a process for preparing a macrocyclic compound of the formula (I): which is carried out using an intermediate of the formula (II): wherein W, Rthrough R, D, A and Rare as defined herein. The compounds of formula (I) are potent active agents for the treatment of hepatitis C virus (HCV) infection.